Please assess the completion status of the following clinical trial:

Trial Title: Closure After Total Shoulder Arthroplasty: Prineo vs Dermabond

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Total shoulder arthroplasty~* Reverse total shoulder arthroplasty~* Age 18-100~* Single Surgeon~Exclusion Criteria:~* Previous shoulder surgery~* Known wound healing complications~* DM, chronic steroid use, vascular insufficiency, morbid obesity (BMI\>40), ESRD, family hx of pathologic scars~* Patients on blood thinners (ASA 81mg ok)~* Connective tissue disease~* Allergy to skin adhesive~* Mentally unable to complete questionnaires~* Previous wound over planned incision

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 100 Years
- Healthy Volunteers: t

Study Arms:
- 2-Octyl Cyanoacrylate and mesh (Type: EXPERIMENTAL): The wound will be closed with 2-Octyl Cyanoacrylate and a mesh
- 2-Octyl Cyanoacrylate (Type: ACTIVE_COMPARATOR): The wound will be closed with just 2-Octyl Cyanoacrylate

Based on this trial design, predict the completion outcome and termination type (if applicable).